Forty Hours of Nutrition, and a Lifetime of Guardrails
United States – March 6, 2026 – Medical schools are adding nutrition hours under HHS pressure, and I want better health without a federal remote control.
Health
-
-
FDA vs. the GLP-1 Gold Rush: Patient Safety, or Monopoly Bodyguarding?
United States – March 5, 2026 – FDA is swatting telehealth sellers of compounded GLP-1s, and we should ask if this is safety or monopoly bodyguard duty.
-
The 37-Million-Pound Carrot Problem
United States – March 4, 2026 – A 37-million-pound frozen-meal recall shows how consolidation turns one cracked carrot into a national hazard.
-
Medicaid Work Rules: Building a Paperwork State to Save a Dollar
United States – March 2, 2026 – Work requirements promise savings, but the first bill is a bigger enforcement bureaucracy and more people losing coverage over paperwork.
-
CMS Just Padlocked Medicare’s Front Door for Some Medical Supply Companies. Fraud Is Real. So Is Power Creep.
United States – February 28, 2026 – CMS froze new Medicare medical-supply enrollments to fight fraud, but emergency-style power needs exit ramps and due process.
-
FDA Opened the Door on a Rare Sinus Disease. Insurers Will Decide Who Walks Through.
United States – February 26, 2026 – FDA greenlit Dupixent for allergic fungal rhinosinusitis; the next fight is coverage, paperwork, and how much of your medical life you must h…
-
The Vaccine Schedule Went Wobbly. The Guardrails Matter More Than Your Team Jersey.
United States – February 25, 2026 – States sued after CDC demoted seven childhood vaccines; the liberty fight is whether public health can skip due process.
-
The 340B Rebate Idea Is Back, and Due Process Is Still on the Wait List
United States – February 24, 2026 – HRSA is reopening the 340B rebate model conversation, and the safety net may end up financing the wait between paying full price and getting …
-
The 340B Rebate Model: When Washington “Fixes” a Discount, Someone Loses the Receipt
United States – February 23, 2026 – HHS is back to tinkering with 340B drug discounts, and the fine print could land on patients, not lobbyists.
-
FDA’s “No Artificial Colors” Loophole: When a Label Stops Speaking English
United States – February 20, 2026 – FDA broadened the “no artificial colors” label by discretion, leaving shoppers to decode loopholes while brands cash in.
End of content
End of content